Genlight MedTech was founded in 2020 in Hangzhou, is a sci-tech platform enterprise focused on industrializing cutting-edge technologies in the fields of neuroscience and neurosurgery. The company has established advanced technology platforms in brain-computer interface, medical lasers, and brain-computer chip, providing innovative instrumental solutions for neurological disorders. Developed products include a magnetic resonance-guided laser ablation system, an implantable closed-loop responsive neurostimulation system for epilepsy and Parkinson's disease, as well as an SEEG electrode, 2 of these products have received breakthrough designation from NMPA.
Genlight MedTech believes in innovation and cares for the welfare of patients. With a global scope and integration between industry and research, we always strive to be a reliable leader in providing solutions in the neuromedical domain.